![](/img/cover-not-exists.png)
A low incidence of hepatocellular carcinoma in patients with genotype 1b compensated cirrhosis treated with paritaprevir/ritonavir, ombitasvir and dasabuvir ± ribavirin in a tertiary center: a matter of better selection?
Chiriac, S., Trifan, A., Stanciu, C., Prelipcean, C.C., Stefanescu, G., Mihai, C., Sfarti, C., Cojocariu, C., Cuciureanu, T., Mihai, F., Singeap, A.M.Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(17)31708-7
File:
PDF, 74 KB
english, 2017